Stock Events

Stock Events

Keros Therapeutics (KROS) Q4 2023 Earnings

28FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-1.37

-1.29

-1.2

-1.12

Details

Expected EPS

-1.374191

Actual EPS

-1.34

Surprise EPS

0.03

Surprise Percent

+2.49%

Description

Keros Therapeutics (KROS) has reported earnings of -1.34 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.